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ABSTRACT
Objectives: This study establishes the South Korean population-based
preference weights for EQ-5D based on values elicited from a representa-
tive national sample using the time trade-off (TTO) method.
Methods: The data for this paper came from a South Korean EQ-5D
valuation study where 1307 representative respondents were invited to
participate and a total of 101 health states deﬁned by the EQ-5D descrip-
tive system were directly valued. Both aggregate and individual level
modeling were conducted to generate values for all 243 health states
deﬁned by EQ-5D. Various regression techniques and model speciﬁcations
were also examined in order to produce the best ﬁt model. Final model
selection was based on minimizing the difference between the observed
and estimated value for each health state.
Results: The N3 model yielded the best ﬁt for the observed TTO value at
the aggregate level. It had a mean absolute error of 0.029 and only 15
predictions out of 101 had errors exceeding 0.05 in absolute magnitude.
Conclusions: The study successfully establishes South Korean population-
based preference weights for the EQ-5D. The value set derived here is
based on a representative population sample, limiting the interpolation
space and possessing better model performance. Thus, this EQ-5D value
set should be given preference for use with the South Korean population.
Keywords: EQ-5D, population values, preference-based measures, time
trade-off.
Introduction
Economic evaluations of health-care interventions provide
important evidence to decision-makers in charge of making efﬁ-
cient resource allocations within their jurisdictions. Quality-
adjusted life year (QALY) is one of a number of measurement
units in cost-utility analysis for economic evaluation. QALY
stands for both quantity and quality of life. To calculate the value
of a QALY, a set of value scores needs to be assigned to each of
the various health states indicating weights for quality of life,
also known as health-related quality of life (HrQoL). It is rec-
ommended that these values be calibrated using social preference
weights elicited from the general population [1]. In addition,
because the preferences for health states can differ across cultures
[2], many countries have measured their own population-based
preference weights for all possible health states. Several methods
to quantify people’s preferences for health status have been
developed; these include visual analog scale (VAS), standard
gamble, time trade-off (TTO), and person trade-off methods [3].
Together with EQ-5D [4], there are other preference-based
health status measures that can be used to classify the health state
of individuals and summarize the change of health outcome in a
single index score. For example, there are the Health Utilities
Index [5], SF-6D [6], and Quality of Well-Being Scale [7]. In
Korea, as in many other countries, there is growing interest
in EQ-5D due to the increasing need of measuring the change in
HrQoL as an outcome of the health care program. The Korean
version of EQ-5D has been under development for some time. Its
reliability and validity has already been proven [8] and it was
included in the Korea National Health and Nutrition Survey,
designed to measure population health in 2005.
In order to develop a population-based preference weights for
EQ-5D (also known as EQ-5D value set), a valuation study was
conducted, in which a subset of health states deﬁned by the
EQ-5D descriptive system was directly valued. Based on these
observed values, a regression modeling approach is adopted to
exploit values for all 243 health states deﬁned by EQ-5D. It must
be noted here that there appears to be reported in the literature
only one earlier study that attempted to develop the EQ-5D value
set for the population in South Korea [9]. However, due to
drawbacks in the design of its valuation study and modeling, the
sample was not nationally representative and the average of
absolute differences between observed and estimated scores was
as great as 0.071. To the authors’ knowledge, to this day the
demand for a representative and reliable EQ-5D value set for
South Korean population is still not met.
The current study establishes the South Korean population-
based preference weights for EQ-5D based on the values elicited
from a national representative sample using the TTO method.
One of the main features of the survey where the preference data
were collected is the number of health states involved in the study.
Unlike previous valuation studies performed in Korea or in other
countries, where either 43 health states deﬁned by EQ-5D or less
were directly valued, here the values for a total of 101 EQ-5D
health states have been directly observed. Thus, with this unique
dataset it is expected that the interpolation spaces in estimating a
value set are minimized in comparison to other value sets.
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Methods
Study Subjects
The target population for the study is Korean adult citizens, aged
20 and older, estimated at 36.786 million based on the ofﬁcial
residential registries on December 31, 2006 [10]. A multistage
stratiﬁed random sampling was employed aiming at generating a
sample representing the age and sex distribution in the target
population. Due to limited resources, the target sample size was
restricted to 1307. The sampling procedure is explained below.
In the ﬁrst step, the entire sample was stratiﬁed using 15
regions (seven large cities and eight provinces) with the exception
of Jeju province, which is an island with a population number
equivalent to 1.2 % of the total population. Due to the relatively
small number of residents in this province, its exclusion was
expected to have only a limited impact on the sampling. The
number of subjects was assigned to 15 regions in proportion to
the population size of each region. The same process was subse-
quently repeated within each region using three categorized
administrative units: “Dong,” “Eup,” and “Myun” (“Dong” is a
town in a district of a city, “Eup” is a main town in a county, and
“Myun” is a township in a county; every address can be catego-
rized into one of these units). In the second step, the ﬁnal ﬁeld-
work locations “Ban” and “Village” (“Ban” is a subdivision of
“Dong” or “Eup,” and “Village” is a subdivision of “Eup” or
“Myun”) were selected randomly within the strata deﬁned in the
ﬁrst step. In the third step, 8 to 10 households were randomly
selected for interview in each “Ban” or “Village.” In those cases
where a selected household had more than two persons aged 20
years or more, the interviewers invited the person whose birthday
was closest within the next 12 months to the day of interview.
Persons residing temporarily at a selected household, such as a
lodger, family member in military service, and persons in long-
period ofﬁcial trips or overseas duty were excluded.
EQ-5D
EQ-5D is one of the most widely used generic index measures of
HrQoL [4]. It consists of two parts, the EQ-5D descriptive
system and the EQ-5D VAS. The descriptive system contains ﬁve
items that measure ﬁve dimensions of health including mobility,
self-care, usual activities, pain/discomfort, and anxiety/
depression. Each dimension is represented by a single item with
three levels of responses: no problem, some problems, and
extreme problems. A total of 243 health states are deﬁned by this
descriptive system. The EQ-5D VAS records the respondent’s
self-rate health status on a VAS, where the endpoints are labeled
“best imaginable health state” and “worst imaginable health
state.” As mentioned earlier, the Korean version of EQ-5D has
already been developed, and its validity and reliability has been
proven [8].
Health State Selection
The survey included 100 EQ-5D health states together with
states “33333” and “11111” for direct valuations. The 100
health states chosen comprise 25 mild, 50 moderate, and 25
severe states. The degree of severity was deﬁned by a standard
city-block distance metric in which any movement away from
“11111” is simply counted for each dimension and aggregated.
For instance, state “11121” and state “21113” are categorized
into distance groups 1 and 3, respectively. Mild states are those
within the distance groups 1 to 4, where there are no level 3
problems and up to three level 2 problems. Severe states are those
within the distance groups 7 to 9, in which there are no level 1
problems and at least two level 3 problems. If a state is neither
mild nor severe, then it is classiﬁed as a moderate state. For
example, although state “21113” is in distance group 3, it would
be categorized not as mild but as a moderate state due to having
a problem of level 3. The 100 health states selected were distrib-
uted into 25 blocks (P. Kind, pers. comm.). To ensure that each
block contained health states across different severities, each
block had six health states composed of two randomly selected
mild states, two severe states, and two moderate states. In the
current study, each participant was assigned two blocks; one was
picked following the numerical order assigned to 25 blocks (i.e.,
the 100th respondent evaluated the 25th block) and the other
was randomly selected. Thus, each participant evaluated 12
health states from two blocks, in addition to the “11111” and
“33333” states. The selection of health states for each of the 25
blocks can be found at: http://www.ispor.org/Publications/value/
ViHsupplementary/ViH12i8_Nam.asp.
Data Collection
The survey instruments and protocol used were similar to those
of the Measurement and Valuation of Health (MVH) study in the
UK [11]. The details of the survey are as follows:
The survey was based on a face-to-face interview that can be
divided into three stages. In the ﬁrst stage, respondents described
their own health at the time of the interview using the validated
Korean version of EQ-5D, including answering the ﬁve-item
descriptive system and self-rated VAS. In the second stage, the
respondents were asked to rank the 12 health states from the two
blocks assigned plus the states “11111” and “33333” by putting
the “best” health state on top and the “worst” at the bottom. It
was assumed that each state was experienced for 10 years fol-
lowed by immediate death. Subsequently, respondents rated the
above ranked 14 health states and the state of immediate death
using VAS.
Finally, each respondent evaluated the same set of health
states but without state “11111” and immediate death using
TTO technique with the double-sided time board and a set of
health state cards. The method is also known as TTO props
method. A thorough description of the method can be found
elsewhere [12] and is therefore not repeated in detail here. In
short, the respondents were ﬁrst asked to decide whether a state
is better or worse than death. For states regarded as better than
death, respondents decided a period of time t in the state
“11111,” which they consider as equivalent to 10 years in the
target state. The shorter t is, the worse the target state. For the
states worse than death, the choice was between dying immedi-
ately and spending a length of time (10 – t) in the target state
followed by t years in the state “11111.” Consequently, the
longer the time chosen to be in the state “11111” to compensate
for a shorter time in the target state, the worse the target state is
[12]. In TTO valuation scale, the states “11111” and immediate
death were treated as anchors and assigned values of 1 and 0,
respectively. Respondents were also surveyed on socioeconomic
background questions after completing the TTO valuation.
The data were collected between February 6 and April 3,
2007. A total of 61 trained interviewers were recruited for this
purpose. On completing the survey, each respondent was
rewarded a gift certiﬁcate equivalent to about 10 US dollars.
Logical Consistency and Exclusion Criteria
The logical consistency approach was applied to examine the
quality of data. Logical consistency is deﬁned as follows: for a
given pair of health states, if state A of a pair is better than the
state B in at least one dimension and not worse in any other, then
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the valuation for the former state (TTOA) must be at least as
good as the valuation for the latter state (TTOB) [13,14]. In a
situation where this rule is breached, the logical inconsistency is
said to occur. For instance, if state “11122” is valued higher than
state “11121,” this is logically inconsistent.
Following the MVH study, respondents were excluded if they
valued less than three states, valued all states the same, valued all
states worse than dead, or if there were four or more logical
inconsistencies. These exclusion criteria take into account
responses with incomplete or unreliable data. The choice of
threshold level (three inconsistencies) is based on Ohinmaa and
Sintonen’s study of the Finnish population [15], where it was
found that involving valuation data with more than three incon-
sistencies would signiﬁcantly affect a derived value set.
Transforming the Data
The observed times t for each investigated health state in the
TTO valuation task were converted into TTO value (h). For the
states valued as better than death, the TTO value h is t/10. For
states worse than death, h is –t/(10 – t). A linear transformation
formula was applied to TTO values for states worse than death
in order to bound negative values to a maximum of –1, where 0
is equivalent to death. This was done as follows [16]:
′ =h h 39 (1)
The lowest value (h) for a state worse than death is –39. This
value occurs when a respondent preferred immediate death over
the course of 3 months in the target state, followed by 9.75 years
in state “11111.” With the above formula, this minimum value
of –39 was transformed to –1.
Statistical Analysis
Modeling method. The analyses were conducted at both aggre-
gate and individual levels. In the aggregate level analysis, the
mean is used to summarize the score of each health state and to
estimate a value set based on the aggregated means. Both ordi-
nary least square (OLS) and weighted least square (WLS) regres-
sions were applied in the aggregate level analysis. The applied
weights in WLS regression takes into account the number of
respondents who rated a particular state. On the other hand, at
the individual level each respondent’s score for a given health
state is introduced into the estimated model. OLS regression
and either a random or ﬁxed effects model, depending on the
Hausman’s test, were employed in the individual level analysis.
The individual effects introduced by participants who might
have systematically valued health states higher or lower can be
eliminated by applying the ﬁxed/random effects model.
Dependent variables. The dependent variable in the regression
analysis was computed as 1 minus the transformed TTO value. It
represents the measure of disutility by subtracting the value of a
given health state from the value of full health. As a result, the
predicted value for state “11111” is equal to 1.
Independent variables. In selecting a model, a range of models
from earlier applications were reviewed. The simplest model is
the main effects model, which comprises 10 dummy variables
that indicate the presence of either a level 2 or 3 in a given
dimension of the evaluated state. For instance, M2 for mobility
level 2, M3 for mobility level 3, SC2 for self-care level 2, SC3 for
self-care level 3, UA2 for usual activities level 2, UA3 for usual
activities level 3, PD2 for pain or discomfort level 2, PD3 for pain
or discomfort level 3, AD2 for anxiety or depression level 2, and
AD3 for anxiety or depression level 3. Unlike the model focusing
on only main effects, other models such as the N3 and D1 models
also take into account the interaction effect. The N3 model
includes the N3 term, indicating whether there is any dimension
on level 3, along with 10 main effect variables. The D1 model
consists of D1, I2, I22, I3, and I32 terms in addition to 10 main
effect variables. The D1 term indicates the number of dimensions
with problems beyond the ﬁrst and replaces the constant term.
The I2 term represents the number of dimensions at level 2
beyond the ﬁrst. The I22 term is the square term of I2. The I3
term represents the number of dimensions at level 3 beyond the
ﬁrst. The I32 term is the square term of I3. The following
interaction terms were also considered in the modeling process:
N2: whether there is any dimension on level 2,
C2: the number of dimensions on level 2,
C2sq: the square of the number of dimensions on level 2,
C3: the number of dimensions on level 3,
C3sq: the square of the number of dimensions on level 3,
X2: whether there are 2 or more dimensions on levels 2 or 3,
X3: whether there are 3 or more dimensions on levels 2 or 3,
X4: whether there are 4 or more dimensions on levels 2 or 3, and
X5: whether there are 5 dimensions on levels 2 or 3
Due to multicollinearity and the large number of possible
combinations of interaction variables, it is not easy to explore all
possible models. Thus, apart from the N3 and D1 models, each
interaction term was examined individually and then new models
were explored by adding the different combinations of the sig-
niﬁcant interaction terms (P < 0.01) to the main effects model,
allowing a maximum of three additional interaction terms. For
the D1 model, only the signiﬁcant interaction terms (P < 0.01)
were kept. The functional form was additive in all models.
Model selection. Given the purpose of this study, the best ﬁtting
model is the one that minimizes the difference between the
observed and the estimated value in each health state. Hence the
overall mean absolute error (MAE) was computed for each inves-
tigated model. The number of absolute errors greater than 0.05
and 0.10 in each model were also used as criteria. Note that due
to the great variability of responses at the individual level, the
goodness-of-ﬁt such as adjusted or overall R2 at this level is
expected to be lower than that at aggregate level analysis.
Various tests were conducted to examine the assumptions
made in the model. The normality of residual was investigated
using Kolmogorov–Smirnov normality test and the Breusch–
Pagan test for examining heteroskedasticity. When heteroskedas-
ticity was found in OLS regression, the standard errors of
coefﬁcients in the model were corrected through the estimation of
HC3 robust standard errors as described by Long and Ervin [17].
Hausman’s test was used to decide between random effects and
ﬁxed effects model. The Ramsey regression equation speciﬁcation
error test (RESET) test for model misspeciﬁcation was also
examined.
To examine the robustness of the chosen model, respondents
were randomly split into two half samples. The coefﬁcients were
ﬁrst estimated from one half and then used to generate estimated
scores and which were then compared with the observed scores
in the other half sample. The ﬁnal value set is then based on the
whole valuation sample.
Comparison of ﬁnal model with other studies. The mean
observed TTO values for EQ-5D health states obtained in the
current study were compared using t-tests to those published by
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Jo et al. [9]. For comparability with Jo et al.’s study, the TTO
values for states worse than death were based on monotonic
transformation. Furthermore, the coefﬁcient estimations from
the main effects model in Jo et al.’s study [9] were compared with
those from the current data set (also with monotonic transfor-
mation) using the same model.
The estimated value set in the current study was compared
with the established value set in other countries such as Japan,
UK, and USA, as well as with the estimation obtained in the
previous Korean study. For this purpose, Spearman’s rank cor-
relation coefﬁcients and mean absolute differences (MADs)
between estimated values from the current study and those from
others were calculated.
Results
Respondent Sample and Valuation Sample
Of the 1307 respondents, a total of 233 (17.8%) had logical
inconsistencies, of which 39 had four or more inconsistencies and
were excluded from the sample. In addition, four other respon-
dents were also excluded: two subjects who gave the same values
for all 13 states measured; and another two who valued all states
as the state worse than dead. As a result, a total of 1264 respon-
dents formed the valuation sample.
Despite the exclusion of 43 participants, as shown in Table 1
the age and sex distribution of the valuation sample was repre-
sentative of the Korean population. Table 2 presents the socio-
demographic and self-reported health characteristics in the total
sample and in the valuation samples. There were no signiﬁcant
differences between the two samples for variables such as edu-
cation, religion, marital status, experience of chronic condition,
and self-reported health problems measured by EQ-5D.
Modeling Analysis
Table 3 presents the coefﬁcient estimates and ﬁt statistics results
for the aggregate level models using OLS and WLS regression.
Only the main effects, N3 and D1 models, are reported here
because other models with different interaction terms did not
perform better than the above three models. The main effects
model based on OLS had an MAE of 0.031 and the number of
absolute errors greater than 0.05 and 0.10 were 20 and 1, respec-
tively. All the coefﬁcient estimations were theoretically consis-
tent, having the expected sign and magnitude. The D1 model
included signiﬁcant interaction terms, D1 and I3, only. Despite
Table 1 Age and sex distribution of total sample and valuation sample compared to South Korean population
Characteristics
Total sample
(n = 1307)
Valuation sample
(n = 1264)
South Korean
population*
Sex (%)
Male 49.04 48.42 49.32
Female 50.96 51.58 50.68
Age, years (%)
20–29 20.81 21.04 20.35
30–39 24.18 24.13 23.81
40–49 23.10 23.26 23.01
50–59 15.00 14.87 15.12
60 or more 16.91 16.69 17.72
*Source: National Statistical Ofﬁce, Republic of Korea.The ofﬁcial residential registries on December 31, 2006 [10].
Table 2 Demographic characteristics of total sample and valuation sample
Characteristics
Total sample
(n = 1307)
Valuation sample
(n = 1264) P-value*
Education, years (%)
6 or less 10.25 10.05 0.116
7–12 52.11 52.61
13 or more 37.64 37.34
Religion (%)
Buddhist 25.79 25.71 0.958
Christian or Catholic 33.82 33.86
Others 0.38 0.40
Unbeliever 39.17 39.16
No answer 0.84 0.87
Marital status (%)
Married 72.61 72.55 0.941
Single 23.87 23.89
Widowed 2.75 2.77
Divorced/separated 0.77 0.79
Experience of chronic condition (%)
Yes 10.41 10.36 0.990
No 89.59 89.64
In EQ-5D, those reporting problems on (%)
Mobility 5.89 5.85 1.000
Self-care 0.77 0.79 1.000
Usual activities 4.05 4.11 0.848
Pain/discomfort 21.27 21.04 0.372
Anxiety/depression 17.44 17.09 0.102
*Comparison between valuation sample and excluded respondents by Chi-square test.
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the different interaction terms involved, the N3 and D1 models
produced identical results with an MAE of 0.029 and the number
of states with absolute errors greater than 0.05 and 0.10 as 15
and 0, respectively. All coefﬁcient estimations in the N3 model
had positive signs. In contrast, the two interaction terms in the
D1 model, the D1 and I3 terms, had negative signs. The negative
sign implies a higher value for a health state with more severe
problems. The results of the main effects, N3 and D1 models
using WLS regression, were generally worse than those based on
OLS regression. Particularly, the number of states with absolute
error greater than 0.05 in the main effects, N3 and D1 models
using WLS regression, were 18, 22 and 20, respectively. A pos-
sible cause could be the outweighed number of values for state
“33333” (n = 1264, SD = 0.44) and, as a result, a greater weight
assigned to this particular state.
Considering the consistency of the coefﬁcient estimations and
minimizing the difference between observed and estimated
values, the N3 model based on OLS regression was selected as
the best performing model at the aggregate level. It passed the
Kolmogorov–Smirnov test for normality of the residuals
(D = 0.083, P = 0.497). There was no model or functional form
misspeciﬁcation as suggested by the Ramsey RESET test
(F = 0.54, P = 0.466). However, it failed the Breusch–Pagan test
for heteroskedasticity (F = 4.92, P = 0.026). Theoretically het-
eroskedasticity in the OLS regression can be addressed by apply-
ing WLS regression. However, the number of absolute errors
greater than 0.05 was signiﬁcantly increased in the results of
applying WLS regression as compared to those resulting from the
OLS. Therefore, the N3 model based on OLS regression is still
preferred. The HC3 procedure was used to correct the biased
standard error of coefﬁcient in the OLS.
The results of modeling at the individual level are shown in
Table 4. Based on OLS regression, four models were identiﬁed,
including themain effects, N3, D1, andX5models. The D1model
here includes I3, I32, and D1 terms. The MAE was 0.031 for the
main effects model and 0.030 for the rest. The number of absolute
errors greater than 0.05 and 0.10 were 18, 22, 20, and 19, and 1,
1, 0, and 2, respectively. All models generated theoretically con-
sistent coefﬁcient estimations, apart from the D1model where the
I3 andD1 terms had negative signs. TheHausman test rejected the
random effects model and in favor of the ﬁxed effects model
(F = 116.89, P < 0.001), therefore only results of the ﬁxed effects
model are reported. There are two models, main effects and N3,
which are based on ﬁxed effects regression and are presented here.
The main effects model had an MAE of 0.032 and the number of
absolute errors greater than 0.05 and 0.10 were 20 and 2, respec-
tively. TheN3model produced similar results: theMAEwas 0.031
and the number of absolute errors greater than 0.05 and 0.10were
20 and 3, respectively.
The differences between the compared models at the indi-
vidual level were marginal and therefore it was difﬁcult to select
one as the best performing. Also most of the models at the
individual level showed signiﬁcant heteroskedasticity, non-
normality of error distribution and model misspeciﬁcation.
For example, the N3 model failed in each of the following
tests: Kolmogorov–Smirnov normality, Breusch–Pagan and
Ramsey RESET (D = 0.086, P < 0.001; F = 1945.99, P < 0.001;
F = 17.90, P < 0.001, respectively).
According to the ﬁndings, the N3 model based on OLS
regression with aggregate data is the best ﬁtting model, minimiz-
ing the difference between the observed and the estimated value
in each health state, and is thus chosen as the ﬁnal model to
estimate the value set. When the model robustness was examined
by comparing the estimated values from one half sample and the
observed values from the other half, both values were highly
correlated (r = 0.983) with an MAE of 0.040.
Predicted values are calculated using the ﬁnal model. For
example, we calculated the predicted values of state “32322” as
follows:
Predicted values = full health – disutility
Full health = 1.000
Disutility for 32322 state = 0.050 + 0.418 (M3) + 0.046 (SC2)
+ 0.208 (UA3) + 0.037 (PD2) + 0.043 (AD2) + 0.050 (N3)
= 0.852.
Predicted values = 1 - 0.852 = 0.148
Table 3 Parameter estimates and ﬁt statistics of aggregate level models using OLS and WLS regression
Variable
OLS WLS
Main effects N3 D1 Main effects N3 D1
Coefﬁcient SE Coefﬁcient SE‡ Coefﬁcient SE Coefﬁcient SE Coefﬁcient SE Coefﬁcient SE
Constant 0.062 0.013 0.050 0.012 0.061 0.013 0.060 0.013
M2 0.097 0.010 0.096 0.009 0.145 0.012 0.087 0.011 0.084 0.011 0.140 0.012
M3 0.429 0.012 0.418 0.012 0.518 0.016 0.422 0.012 0.415 0.012 0.523 0.018
SC2 0.043 0.010 0.046 0.009 0.096 0.013 0.044 0.010 0.043 0.010 0.098 0.012
SC3 0.148 0.011 0.136 0.013 0.235 0.017 0.164 0.011 0.158 0.012 0.264 0.019
UA2 0.053 0.011 0.051 0.011 0.101 0.012 0.050 0.011 0.047 0.011 0.099 0.012
UA3 0.223 0.011 0.208 0.014 0.308 0.014 0.221 0.012 0.213 0.012 0.318 0.016
PD2 0.039 0.010 0.037 0.009 0.086 0.013 0.039 0.010 0.036 0.010 0.087 0.013
PD3 0.166 0.011 0.151 0.013 0.250 0.016 0.175 0.011 0.168 0.012 0.268 0.018
AD2 0.046 0.010 0.043 0.010 0.093 0.013 0.046 0.010 0.042 0.010 0.093 0.012
AD3 0.175 0.011 0.158 0.012 0.258 0.015 0.182 0.011 0.173 0.012 0.275 0.016
N3 0.050 0.016† 0.027 0.014*
I3 –0.050 0.014 –0.102 0.023
I32 0.012 0.003
D1 –0.050 0.013 –0.048 0.013
Adjusted R2 0.980 0.984 0.996 0.987 0.988 0.997
MAE 0.031 0.029 0.029 0.031 0.030 0.030
No. (of 101) >0.05 20 15 15 18 22 20
No. (of 101) >0.1 1 0 0 1 1 0
*P > 0.05; 0.001 < †P < 0.01; otherwise P 0.001.
‡HC3 robust standard error.
M2, mobility level 2; M3, mobility level 3; SC2, self-care level 2; SC3, self-care level 3; UA2, usual activities level 2; UA3, usual activities level 3; PD2, pain or discomfort level 2; PD3, pain or
discomfort level 3;AD2, anxiety or depression level 2; AD3, anxiety or depression level 3; N3, any dimension on level 3; I3, the number of dimensions at level 3 beyond the ﬁrst; I32, the square
term of I3; D1, the number of dimensions with problems beyond the ﬁrst; MAE, mean absolute error; OLS, ordinary least square; WLS, weighted least square; SE, standard error.
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The observed and predicted means and the difference between
the two values can be found at: http://www.ispor.org/
Publications/value/ViHsupplementary/ViH12i8_Nam.asp.
Comparison with Previous Korean Study and
Other Studies
Among 23 health states in common, nine health states had sig-
niﬁcantly lower observed means in the current study than in Jo
et al.’s [9], including ﬁve severe and two moderate states. Such
differences are translated into the coefﬁcient estimations in the
model. With the same transformation method for a state worse
than death and model speciﬁcation, all coefﬁcient estimations for
level 3 are higher for all dimensions apart from self-care in the
current study. The biggest magnitude is observed in the mobility
dimension with almost a twofold increase (from 0.310 in Jo
et al.’s to 0.606 here).
In comparison with other studies, the value set obtained from
our ﬁnal model is highly correlated with the ofﬁcial value set in
Japan (r = 0.969, P < 0.001), USA (r = 0.908, P < 0.001), and
UK (r = 0.855, P < 0.001), respectively. The MAD between our
Korean study and Japan is 0.056, with USA it is 0.105 and with
the UK it is 0.322.
Discussion
This study collected TTO values for 101 EQ-5D health states
from a South Korean representative sample. Based on these
values the population-based preference weights for EQ-5D are
developed using the N3 model. This model yields the best ﬁt for
the observed TTO value at aggregate level, with an MAE of
0.029 and only 15 (out of a total 101) prediction errors exceed-
ing 0.05 in absolute magnitude.
At the aggregate level, despite the D1 model producing iden-
tical results to the N3 model, the negative sign of coefﬁcient
estimations for both interaction terms in the D1 model make it
less transparent in calculation. It also becomes conceptually dif-
ﬁcult to understand why, for instance, health states with more
level 3 problems result in an increased value. Thus, the N3 model
is preferred.
The empirical comparisons between modeling at aggregate
and individual levels in the current study support the use of
aggregate level analysis. However, the choice of either aggregate
or individual level based analysis is an ongoing debate. Advan-
tages associated with the aggregate level approach include simple
modeling, easy interpretation, and being intuitive. On the other
hand, the advantages associated with the individual level
approach include utilizing the maximum amount of information
and treating each respondent’s value on an equal basis. Theoreti-
cally, individual level analyses might be expected to produce
better results with their capacity to adjust for individual effects.
However, in practice it is commonly found that there is too much
noise in individual level data that hinders the performance of the
estimates. In contrast, aggregate level analysis can alleviate such
a problem by regressing at aggregate measures to minimize the
unwanted variations.
The choice of central tendency measures, such as the mean or
median in the aggregate level analysis, is a debatable issue and
the exploration of the impact of the choice of central tendency is
beyond the scope of this study.
Compared with other valuation studies, the major contribu-
tion of the current study is the number of health states that were
directly valued. Unlike other studies, either following the 43
EQ-5D health states in the MVH project or decreasing the
number of health states investigated to fewer than 43, this study
increases the number of health states. A total of 101 health states
were valued, of which 23 overlap with the health states in the
MVH set. Therefore, there are at least 2.4 times more health
states investigated than in other studies, covering almost 42% of
the total health states (101/243) deﬁned by the EQ-5D descrip-
tive system. As a result, this study provides more information
regarding how values (observed) are distributed in the valuation
Table 4 Parameter estimates and ﬁt statistics of individual level models using OLS and ﬁxed effect regression
Variable
OLS FE
Main effects N3 D1 X5 Main effects N3
Coefﬁcient SE† Coefﬁcient SE† Coefﬁcient SE Coefﬁcient SE† Coefﬁcient SE Coefﬁcient SE
Constant 0.061 0.007 0.060 0.007 0.082 0.008 0.057 0.007 0.057 0.007
M2 0.087 0.006 0.084 0.006 0.140 0.008 0.079 0.006 0.088 0.005 0.086 0.005
M3 0.422 0.008 0.415 0.008 0.523 0.013 0.412 0.009 0.428 0.006 0.424 0.006
SC2 0.044 0.006 0.043 0.006 0.098 0.009 0.034 0.006 0.039 0.005 0.039 0.005
SC3 0.164 0.007 0.158 0.008 0.264 0.013 0.155 0.008 0.158 0.006 0.155 0.006
UA2 0.050 0.006 0.047 0.006 0.099 0.008 0.042 0.006 0.049 0.005 0.047 0.005
UA3 0.221 0.007 0.213 0.008 0.318 0.012 0.212 0.008 0.220 0.006 0.215 0.006
PD2 0.039 0.006 0.036 0.006 0.087 0.009 0.030 0.006 0.040 0.005 0.039 0.005
PD3 0.175 0.008 0.168 0.008 0.268 0.013 0.162 0.008 0.183 0.006 0.179 0.006
AD2 0.046 0.006 0.042 0.006 0.093 0.009 0.037 0.006 0.051 0.005 0.049 0.005
AD3 0.182 0.007 0.173 0.008 0.275 0.012 0.172 0.008 0.182 0.006 0.176 0.006
N3 0.027 0.009* 0.017 0.007*
I3 –0.102 0.016
I32 0.012 0.002
D1 –0.048 0.009
X5 0.031 0.010*
Adjusted R2 0.533 0.533 0.801 0.533 0.533 0.533
MAE 0.031 0.030 0.030 0.030 0.032 0.031
No. (of 101) >0.05 18 22 20 19 20 20
No. (of 101) >0.1 1 1 0 2 2 3
0.001 < *P < 0.01; otherwise P < 0.001.
†HC3 robust standard error.
M2, mobility level 2; M3, mobility level 3; SC2, self-care level 2; SC3, self-care level 3; UA2, usual activities level 2; UA3, usual activities level 3; PD2, pain or discomfort level 2; PD3, pain or
discomfort level 3; AD2, anxiety or depression level 2; AD3, anxiety or depression level 3; N3, any dimension on level 3; I3, the number of dimensions at level 3 beyond the ﬁrst; I32, the
square term of I3; D1, the number of dimensions with problems beyond the ﬁrst; X5, whether there are 5 dimensions on levels 2 or 3; MAE, mean absolute error; OLS, ordinary least square;
FE, ﬁxed effect regression; SE, standard error.
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space deﬁned by EQ-5D, and consequently it limited the inter-
polation space in the estimations.
There are three possible ways to transfer the TTO value for
states worse than death: monotonic, linear, and truncated trans-
formations [16]. The choice of transformation method in our
study was purely based on empirical evidence showing that the
linear transformation results in the smallest MAE amongst the
three methods. There is no theoretical ground for the choice of
one method over another. However, there should be awareness of
the effect of applying different transformations in the resulting
EQ-5D value set and consequently on the cost-effectiveness
analysis. For instance, the value set based on linear transforma-
tion produces a smaller range of values and therefore the QALY
estimation, and possibly QALY gain, will be smaller than those
estimated from a value set based on monotonic transformations.
A possible contribution to the discrepancies in observed TTO
values and, consequently, coefﬁcient estimation between the
current study and Jo et al.’s [9] is the sampling difference. The
sampling in our study is from 15 regions representing the whole
country (except the Jeju region), while in the latter study it was
conﬁned to two adjacent regions only (Seoul and Gyeonggi-do).
Our data suggests that the values obtained from the other 13
regions are different from values elicited from Seoul and
Gyeonggi-do regions (data not shown). Therefore, the values
elicited from these two regions alone cannot be used as a repre-
sentative preference for the population in South Korea as a whole.
Another possible explanation for differences in coefﬁcient
estimations between the two studies could be the number of
health states involved. In this study there are 101 health states
with directly observed values, whereas Jo et al. [9] use only 42
states. In other words, in our study there is more information
available regarding the valuation space deﬁned by EQ-5D, and
therefore it minimizes the interpolation spaces in the estimation.
Particularly, this study values 26 severe health states directly. In
contrast, only seven severe health states were investigated in the
latter study. Thus, the coefﬁcient estimation for level 3 problems
is likely to be more robust in the current study.
We are conﬁdent that the EQ-5D preference weights devel-
oped in this study are better than the ones published previously
and should be used preferentially for South Korean population.
There are three main reasons for this: First, the data was col-
lected from a national representative sample. Second, it is based
on the values of 101 health states, which is twice the number of
health states used in the earlier study and, on average each health
state (apart from state “33333”) has about 150 observations
to provide a reliable estimate. Finally, the performance of the
chosen model in our study is superior to the ﬁnal model in the
previous study in terms of the size of MAE and of the proportion
of health states with an absolute estimation error greater than
0.05 and 0.10.
When considering the correlation coefﬁcients and MADs
between the estimated value set in the current study and the
ofﬁcial value set in other studies, the estimates here are closer to
values in the Japanese study than those in the USA and UK. This
observation could represent the cultural similarity between
Korea and Japan which was also observed in the previous Korean
study [7].
In conclusion, the study successfully establishes a set of South
Korean population-based preference weights for the EQ-5D. The
value set derived here is based on a population representative
sample, limiting the interpolating space and possessing better
model performance. Thus, this EQ-5D value set should be used
preferentially for the South Korean population.
Source of ﬁnancial support: This study was prepared by ﬁnancial support
of Korea Centers for Disease Control and Prevention (KCDC) in the
Ministry of Public Health and Social Welfare.
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